scispace - formally typeset
M

Mark P. Mattson

Researcher at Johns Hopkins University School of Medicine

Publications -  988
Citations -  151506

Mark P. Mattson is an academic researcher from Johns Hopkins University School of Medicine. The author has contributed to research in topics: Glutamate receptor & Neuroprotection. The author has an hindex of 200, co-authored 980 publications receiving 138033 citations. Previous affiliations of Mark P. Mattson include University of Kentucky & National Institutes of Health.

Papers
More filters
Journal ArticleDOI

Secreted forms of β‐amyloid precursor protein modulate dendrite outgrowth and calcium responses to glutamate in cultured embryonic hippocampal neurons

TL;DR: Secreted forms of the beta-amyloid precursor protein (APPss) counteracted the inhibitory effect of glutamate on dendrite outgrowth in cultured embryonic hippocampal neurons and may play a role in developmental and synaptic plasticity by modulating dendritic responses to glutamate.
Journal ArticleDOI

Impact of lysosome status on extracellular vesicle content and release.

TL;DR: A better understanding of the molecular mechanisms that regulate trafficking of MVBs to lysosomes and the plasma membrane may advance an understanding of diseases in which pathogenic proteins, lipids or infectious agents accumulate within or outside of cells.
Journal ArticleDOI

3-Hydroxybutyrate regulates energy metabolism and induces BDNF expression in cerebral cortical neurons

TL;DR: It is found that 3OHB metabolism increases mitochondrial respiration which drives changes in expression of brain‐derived neurotrophic factor (BDNF) in cultured cerebral cortical neurons.
Journal ArticleDOI

Role of Cyclic GMP in the Regulation of Neuronal Calcium and Survival by Secreted Forms of β‐Amyloid Precursor

TL;DR: Data suggest that APPss mediate their [Ca2+]i‐lowering and excitoprotective effects on target neurons through increases in cGMP levels.
Journal ArticleDOI

Altered calcium homeostasis and mitochondrial dysfunction in cortical synaptic compartments of presenilin-1 mutant mice.

TL;DR: It is reported that synaptosomes prepared from transgenic mice harboring presenilin‐1 mutations exhibit enhanced elevations of cytoplasmic calcium levels following exposure to depolarizing agents, amyloid β‐peptide, and a mitochondrial toxin compared with synaptoomes from nontransgenic mice and mice overexpressing wild‐type presenILin‐ 1.